Quantitative application of dual-phase 99mTc-sestamibi SPECT/CT imaging of parathyroid lesions: identification of optimal timing in secondary hyperparathyroidism

Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13(6):952–61. https://doi.org/10.2215/CJN.10390917.

Article  PubMed  PubMed Central  Google Scholar 

Mizobuchi M, Ogata H, Koiwa F. Secondary hyperparathyroidism: pathogenesis and latest treatment. Ther Apher Dial. 2019;23(4):309–18. https://doi.org/10.1111/1744-9987.12772.

Article  PubMed  Google Scholar 

Schneider R, Slater EP, Karakas E, et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg. 2012;36(2):318–26. https://doi.org/10.1007/s00268-011-1392-0.

Article  PubMed  Google Scholar 

Caldarella C, Treglia G, Pontecorvi A, et al. Diagnostic performance of planar scintigraphy using 99mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med. 2012;26(10):794–803. https://doi.org/10.1007/s12149-012-0643-y.

Article  PubMed  Google Scholar 

Apetrii M, Goldsmith D, Nistor I, et al. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD)—a systematic review and meta-analysis. PLoS ONE. 2017;12(11):e0187025. https://doi.org/10.1371/journal.pone.0187025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jovanovska A, Stoilovska B, Mileva M, et al. Absent 99mTc-MIBI uptake in the thyroid gland during early phase of parathyroid scintigraphy in patients with primary and secondary hyperparathyroidism. Open Access Maced J Med Sci. 2018;6(5):808–13. https://doi.org/10.3889/oamjms.2018.118.

Article  PubMed  PubMed Central  Google Scholar 

Hiramitsu T, Tomosugi T, Okada M, et al. Pre-operative localisation of the parathyroid glands in secondary hyperparathyroidism: a retrospective cohort study. Sci Rep. 2019;9(1):14634. https://doi.org/10.1038/s41598-019-51265-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reitz RJ, Dreimiller A, Khil A, et al. Ectopic and supernumerary parathyroid glands in patients with refractory renal hyperparathyroidism. Surgery. 2021;169(3):513–8. https://doi.org/10.1016/j.surg.2020.08.007.

Article  PubMed  Google Scholar 

Xue J, Liu Y, Ji T, et al. Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Nucl Med Commun. 2018;39(12):1129–37. https://doi.org/10.1097/MNM.0000000000000921.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keidar Z, Solomonov E, Karry R, et al. Preoperative [99mTc]MIBI SPECT/CT interpretation criteria for localization of parathyroid adenomas-correlation with surgical findings. Mol Imaging Biol. 2017;19(2):265–70. https://doi.org/10.1007/s11307-016-1013-2.

Article  CAS  PubMed  Google Scholar 

Garcia-Talavera P, Diaz-Soto G, Montes AA, et al. Contribution of early SPECT/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: diagnostic value and correlation between uptake and biological parameters. Rev Esp Med Nucl Imagen Mol. 2016;35(6):351–7. https://doi.org/10.1016/j.remn.2016.03.001.

Article  CAS  PubMed  Google Scholar 

Kairemo K, Jessop AC, Vija AH, et al. A prospective comparative study of using ultrasonography, 4D-CT and parathyroid dual-phase scintigraphy with SPECT in patients with primary hyperparathyroidism. Diagnostics (Basel). 2021. https://doi.org/10.3390/diagnostics11112006.

Article  PubMed  Google Scholar 

Petranovic Ovcaricek P, Giovanella L, Carrio Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801–22. https://doi.org/10.1007/s00259-021-05334-y.

Article  PubMed  PubMed Central  Google Scholar 

Zhang R, Zhang Z, Huang P, et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed (99m)Tc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging. 2020;20(1):91. https://doi.org/10.1186/s12880-020-00490-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hunter K, Gavin N, McQuade C, et al. Optimal timing of SPECT/CT to demonstrate parathyroid adenomas in 99mTc-sestamibi scintigraphy. Nucl Med Rev Cent East Eur. 2022;25(2):89–94. https://doi.org/10.5603/NMR.a2022.0020.

Article  PubMed  Google Scholar 

Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48(7):1084–9. https://doi.org/10.2967/jnumed.107.040428.

Article  PubMed  Google Scholar 

Mandal R, Muthukrishnan A, Ferris RL, et al. Accuracy of early-phase versus dual-phase single-photon emission computed tomography/computed tomography in the localization of parathyroid disease. Laryngoscope. 2015;125(6):1496–501. https://doi.org/10.1002/lary.25020.

Article  PubMed  Google Scholar 

Formanek M, Dedek V, Kolacek M, et al. Individualised timing of radio-guided parathyroidectomy using multi-phase SPECT/CT increases in vivo sensitivity and accuracy and reduces operating time: a randomised clinical trial. Diagnostics (Basel). 2021. https://doi.org/10.3390/diagnostics11040677.

Article  PubMed  Google Scholar 

Havel M, Dedek V, Kolacek M, et al. Quantitative analysis in parathyroid adenoma scintigraphy. Nucl Med Commun. 2022;43(1):1–7. https://doi.org/10.1097/MNM.0000000000001474.

Article  CAS  PubMed  Google Scholar 

Peters SMB, van der Werf NR, Segbers M, et al. Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study. EJNMMI Phys. 2019;6(1):29. https://doi.org/10.1186/s40658-019-0268-5.

Article  PubMed  PubMed Central  Google Scholar 

Robin P, Klein R, Gardner J, et al. Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity. Nucl Med Commun. 2019;40(5):469–76. https://doi.org/10.1097/MNM.0000000000000996.

Article  CAS  PubMed  Google Scholar 

Erbil Y, Kapran Y, Issever H, et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg. 2008;195(1):34–9. https://doi.org/10.1016/j.amjsurg.2007.01.040.

Article  PubMed  Google Scholar 

Sun PY, Thompson SM, Andrews JC, et al. Selective parathyroid hormone venous sampling in patients with persistent or recurrent primary hyperparathyroidism and negative, equivocal or discordant noninvasive imaging. World J Surg. 2016;40(12):2956–63. https://doi.org/10.1007/s00268-016-3621-z.

Article  PubMed  Google Scholar 

Jiang SQ, Yang T, Zou Q, et al. The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with (99m)Tc-MIBI planar scintigraphy and ultrasonography. BMC Med Imaging. 2020;20(1):115. https://doi.org/10.1186/s12880-020-00517-9.

Article  PubMed  PubMed Central  Google Scholar 

Listewnik MH, Piwowarska-Bilska H, Kurantowicz M, et al. Semi-quantitative method for the assessment of focal lesions in parathyroid scintigraphy with relation to histopathology: a prospective study. Nucl Med Rev Cent East Eur. 2017;20(1):18–24. https://doi.org/10.5603/NMR.a2016.0038.

Article  PubMed  Google Scholar 

Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126(6):1023–8. https://doi.org/10.1067/msy.2099.101578. (discussion 8-9).

Article  CAS  PubMed  Google Scholar 

Ma J, Yang J, Chen C, et al. Use of 99mTc-sestamibi SPECT/CT imaging in predicting the degree of pathological hyperplasia of the parathyroid gland: semi-quantitative analysis. Quant Imaging Med Surg. 2021;11(10):4375–88. https://doi.org/10.21037/qims-21-66.

Article  PubMed  PubMed Central  Google Scholar 

Zhang M, Sun L, Rui W, et al. Semi-quantitative analysis of 99mTc-sestamibi retention level for preoperative differential diagnosis of parathyroid carcinoma. Quant Imaging Med Surg. 2019;9(8):1394–401. https://doi.org/10.21037/qims.2019.07.02.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li P, Liu Q, Tang D, et al. Lesion based diagnostic performance of dual phase 99mTc-MIBI SPECT/CT imaging and ultrasonography in patients with secondary hyperparathyroidism. BMC Med Imaging. 2017;17(1):60. https://doi.org/10.1186/s12880-017-0235-3.

Article  PubMed  PubMed Central  Google Scholar 

Suh HY, Na HY, Park SY, et al. The usefulness of maximum standardized uptake value at the delayed phase of Tc-99m sestamibi single-photon emission computed tomography/computed tomography for identification of parathyroid adenoma and hyperplasia. Medicine (Baltimore). 2020;99(28):e21176. https://doi.org/10.1097/MD.0000000000021176.

Article  CAS  PubMed  Google Scholar 

Ding Y, Zou Q, Jin Y, et al. Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease. Int Urol Nephrol. 2020;52(1):155–9. https://doi.org/10.1007/s11255-019-02330-y.

Article  CAS  PubMed  Google Scholar 

Lomonte C, Vernaglione L, Chimienti D, et al. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism? Clin J Am Soc Nephrol. 2008;3(3):794–9. https://doi.org/10.2215/CJN.04150907.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaur P, Gattani R, Singhal AA, et al. Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: data from single institution in India. Indian J Endocrinol Metab. 2016;20(5):625–30. https://doi.org/10.4103/2230-8210.190540.

Article  PubMed  PubMed Central  Google Scholar 

Arya AK, Bhadada SK, Singh P, et al. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas. Sci Rep. 2017;7(1):3123. https://doi.org/10.1038/s41598-017-03143-8.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif